Focused Ultrasound and a Digital Health Platform for Addiction Treatment

Overview

In this interview, Dr. Ali Rezai outlines addiction as a chronic brain disease and explains how focused ultrasound neuromodulation targeting the nucleus accumbens, paired with a digital health platform that uses wearables and AI to predict cravings, could enhance existing treatments.

• Addiction is framed as a brain disease with biological, psychological, and social components
• Focused ultrasound aims to reset craving loops in the brain
• A digital health platform monitors cravings and stress with wearables and EMR data
• Early results show significant craving and use reductions; therapy is not a stand-alone cure

Overview

The podcast features Meghan Hall speaking with Dr. Ali Rezai about addiction as a chronic brain disease and a new approach to treatment that combines focused ultrasound neuromodulation with a digital health platform. The conversation emphasizes integrating brain-based therapies with traditional care and social supports to improve outcomes for people with substance use and behavioral addictions.

State of Addiction in the United States

The host notes that nearly 50 million Americans struggle with substance addictions and that behavioral addictions such as gambling affect millions more. The societal costs are vast, including healthcare expenses, reduced workforce participation, homelessness, and criminal justice burdens. Rezai argues for viewing addiction as a chronic brain disease with interwoven biological, psychological, and social factors and for building a coordinated, long-term care ecosystem rather than treating addiction as a moral failing.

Current Treatments and Effectiveness

The discussion reviews standard treatments: talk therapy, behavioral therapy, medications for opioid use disorders such as methadone and Suboxone, and 12-step programs. There are limited pharmacological options for stimulant addictions like methamphetamine and cocaine. The effectiveness of treatments improves when care is integrated with ongoing follow-up and family involvement, reinforcing the need for a comprehensive ecosystem of care.

Focused Ultrasound for Addiction

Focused ultrasound uses multiple beams converging at a precise brain target, the nucleus accumbens, to modulate the reward circuitry involved in cravings and compulsive seeking behaviors. Rezai describes the mechanism as interrupting the craving loop and helping the brain re-balance. The procedure is noninvasive and performed in a chair with a helmet-like device. In studies conducted over six years, about 50 patients with severe, treatment-resistant addiction showed significant reductions in cravings and drug use after a single 20-minute session. While promising, the technique remains investigational, with NIH-sponsored sham-controlled trials in progress and not yet FDA approved.

Results and Potential

Early results suggest reductions in cravings and improvements in function, with reductions in drug use reported by participants. Rezai emphasizes that ultrasound-based neuromodulation is not a cure but a tool to amplify the effectiveness of existing therapies such as talk therapy, medications, and social supports. The approach could reduce biological impediments to recovery and enable better engagement with the broader treatment ecosystem.

Integrated Addiction Care Ecosystem

The interview underscores the necessity of coupling neuromodulation with a holistic care framework, including medications, behavioral therapies, peer supports, housing, transportation, and employment reintegration. The goal is to restore sobriety, rebuild families, and re-integrate individuals into their communities and workforce.

The Human Operating System and Digital Health

Rezai introduces the human operating system, a digital health platform that aggregates data from wearables such as the Apple Watch, Oura Ring, and other devices, along with apps and electronic health records. The AI backbone analyzes sleep patterns, heart rate variability, cravings, and stress to generate predictive models of relapse risk. Alerts and insights are designed to empower physicians, nurses, psychologists, and peer recovery specialists in field settings to intervene proactively. Privacy is prioritized with HIPAA-compliant data handling and explicit permissions; the system also supports social determinants of health such as housing and childcare to facilitate recovery and life reintegration.

Rural Context and Scaling

The West Virginia context provides a testing ground for deploying a digital ecosystem in a rural setting, with plans to scale the model to other communities and states. Rezai envisions nationwide partnerships and broader applications across addiction and related neurological and mental health conditions.

Conclusion

The podcast frames addiction as a chronic brain disease that may be addressed through a combination of neuromodulation and comprehensive care. The work represents a potential shift in addiction treatment, bridging brain-based interventions with therapy, social supports, and digital health tools to improve long-term outcomes.